Literature DB >> 1003443

Genetic polymorphism and interethnic variability of plasma paroxonase activity.

J R Playfer, L C Eze, M F Bullen, D A Evans.   

Abstract

A method for determining plasma paroxonase activity using an auto-analyser is described. Frequency distributions for British and Indian subjects show bimodality. A study of 40 British families confirms the presence of a genetic polymorphism with regard to plasma paroxonase activity. Two phenotypes can be defined, controlled by two alleles at one autosomal locus. The frequency of the low activity phenotype is less in the Indian population than in the British population. Malay, Chinese, and African subjects fail to show obvious bimodality.

Mesh:

Substances:

Year:  1976        PMID: 1003443      PMCID: PMC1013436          DOI: 10.1136/jmg.13.5.337

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  7 in total

1.  Hydrolysis of paraoxon in mammalian blood.

Authors:  E G ERDOS; L E BOGGS
Journal:  Nature       Date:  1961-05-20       Impact factor: 49.962

2.  Preparation and determination of diethyl p-nitrophenyl phospate (E 600) a drug used in the treatment of glaucoma.

Authors:  L FAGERLIND; B HOLMSTEDT; O WALLEN
Journal:  Sven Farm Tidskr       Date:  1952-05-20

3.  A comparative study of the rates of metabolism, L.D. 50's and antiacetylcholinesterase activities of three diethylphosphoryl esters of quinolinols.

Authors:  D G Satchell
Journal:  Aust J Exp Biol Med Sci       Date:  1973-10

Review 4.  Metabolism of insecticides in plants and animals.

Authors:  T R Fukuto; R L Metcalf
Journal:  Ann N Y Acad Sci       Date:  1969       Impact factor: 5.691

5.  [Genetically determined polymorphism of human serum paraoxonase (EC 3.1.1.2)].

Authors:  H H Lindorf; M Petenyi; M Flügel; T Fischer; T Hiller
Journal:  Humangenetik       Date:  1973

6.  [Enzymatic hydrolysis of diethyl-p-nitrophenylphosphate (E 600) by human serum].

Authors:  K Krisch
Journal:  Z Klin Chem Klin Biochem       Date:  1968-01

7.  The purification of the enzyme hydrolysing diethyl p-nitrophenyl phosphate (paraoxon) in sheep serum.

Authors:  A R MAIN
Journal:  Biochem J       Date:  1960-01       Impact factor: 3.857

  7 in total
  32 in total

Review 1.  Development of analytical technology in pharmacogenetic research.

Authors:  Ann K Daly
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-25       Impact factor: 3.000

2.  Serum arylesterase and paraoxonase activity in patients with chronic hepatitis.

Authors:  Suleyman Sirri Kilic; Suleyman Aydin; Nermin Kilic; Fazilet Erman; Suna Aydin; Ilhami Celik
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

Review 3.  The human serum paraoxonase/arylesterase polymorphism.

Authors:  B N La Du
Journal:  Am J Hum Genet       Date:  1988-09       Impact factor: 11.025

4.  Activity of esterases in plasma from Ghanaian and British subjects.

Authors:  F M Williams; E N Nicholson; N W Woolhouse; K K Adjepon-Yamoah; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  8-Hydroxydeoxyguanosine levels in human leukocyte and urine according to exposure to organophosphorus pesticides and paraoxonase 1 genotype.

Authors:  Chul-Ho Lee; Michihiro Kamijima; Heon Kim; Eiji Shibata; Jun Ueyama; Takayoshi Suzuki; Kenji Takagi; Isao Saito; Masahiro Gotoh; Hatsuki Hibi; Hisao Naito; Tamie Nakajima
Journal:  Int Arch Occup Environ Health       Date:  2006-08-17       Impact factor: 3.015

Review 6.  Pharmacogenetics and ecogenetics.

Authors:  D P Agarwal; H W Goedde
Journal:  Experientia       Date:  1986-10-15

Review 7.  Clinical significance of esterases in man.

Authors:  F M Williams
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

8.  Effect of efavirenz on high-density lipoprotein antioxidant properties in HIV-infected patients.

Authors:  S A Pereira; J R Batuca; U Caixas; T Branco; J Delgado-Alves; I Germano; F Lampreia; E C Monteiro
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

Review 9.  Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity.

Authors:  Lucio G Costa; Gennaro Giordano; Toby B Cole; Judit Marsillach; Clement E Furlong
Journal:  Toxicology       Date:  2012-07-31       Impact factor: 4.221

10.  High prevalence of low serum paraoxonase-1 in subjects with coronary artery disease.

Authors:  Narayani Jayakumari; Gopalan Thejaseebai
Journal:  J Clin Biochem Nutr       Date:  2009-10-28       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.